← Back to Clinical Trials
Recruiting NCT02402244

Project: Every Child for Younger Patients With Cancer

Trial Parameters

Condition Adrenal Gland Pheochromocytoma
Sponsor Children's Oncology Group
Study Type OBSERVATIONAL
Phase N/A
Enrollment 75,000
Sex ALL
Min Age N/A
Max Age 25 Years
Start Date 2015-11-03
Completion 2030-12-31
Interventions
Cytology Specimen Collection ProcedureMedical Chart Review

Brief Summary

This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

Eligibility Criteria

Inclusion Criteria: * Enrollment must occur within 6 months of initial disease presentation OR within 6 months of refractory disease, disease progression, disease recurrence, second or secondary malignancy, or post-mortem * Patients previously enrolled on ACCRN07 are eligible to enroll on Tracking Outcome, Registry and Future Contact components of APEC14B1 any time after they reach age of majority * Patients with a known or suspected neoplasm that occurs in the pediatric, adolescent or young adult populations are eligible for enrollment as follows: * All cancer cases with an International Classification of Diseases for Oncology (ICD-O) histologic behavior code of one "1" (borderline), two "2" (carcinoma in situ) or three "3" (malignant) * All neoplastic lesions of the central nervous system regardless of behavior, i.e., benign, borderline or malignant * All neoplastic lesions of the kidney regardless of behavior, i.e., benign, borderline or malignant * The following other benign/border

Related Trials